Starling Oncology, Inc. Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities
Starling Oncology, Inc. (STLN) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities of 0 shares for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Income Statement
us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities · last filed 2024-03-28
- Starling Oncology, Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2022-09-30 was 7.40M shares.
- Starling Oncology, Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2021-09-30 was 0.00 shares.
- Starling Oncology, Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2023 was 0.00 shares, a 100.00% decline from fiscal 2022.
- Starling Oncology, Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2022 was 5.10M shares.
- Starling Oncology, Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2021 was 0.00 shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 3 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 9 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 9 month as first filed | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 12 month |
|---|---|---|---|---|
| 2023-12-31 | 0.00 shares 10-K · filed 2024-03-28 | |||
| 2023-09-30 | 0.00 shares 10-Q · filed 2023-11-08 | |||
| 2022-12-31 | 5.10M shares 10-K · filed 2024-03-28 | |||
| 2022-09-30 | 7.40M shares 10-Q · filed 2022-11-09 | 7.40M shares 10-Q · filed 2023-11-08 | 2.49M shares 10-Q · filed 2022-11-09 | |
| 2021-12-31 | 0.00 shares 10-K · filed 2023-03-16 | |||
| 2021-09-30 | 0.00 shares 10-Q · filed 2022-11-09 | 0.00 shares 10-Q · filed 2022-11-09 |